Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Tesaro Stock Soars After Announcing Agreeing to Be Bought By ...
Gsk tesaro | PPTX
GSK to buy cancer drugmaker Tesaro for $5.1 billion
Tesaro announces FDA approval of Zejula for women with... | CPHI Online
GlaxoSmithKline announces purchase of Tesaro - UPI.com
TESARO ANNOUNCES THE LAUNCH OF VARUBI™ (ROLAPITANT) IN THE UNITED STATES
GlaxoSmithKline agrees to buy Tesaro for $5.1 billion
Tesaro acquisition set to boost GlaxoSmithKline drug development
Tesaro Announces U.S. Fda Approval Of Zejula™ (Niraparib) Ovarian Cancer
GSK slides after buying cancer firm Tesaro for hefty $5.1 billion
GSK / TESARO booth at ESMO. I really liked how the Zejula success was ...
GSK Subsidiary TESARO Sues AnaptysBio: Understanding the Legal Battle ...
GSK arm Tesaro initiates litigation against AnaptysBio
Tesaro Stock Flies On $5.1 Billion GlaxoSmithKline Bid| Investor's ...
GSK Buys Tesaro For $5 Billion In Dramatic Bet On Cancer Genetics
GSK to Acquire PARP Inhibitor Developer Tesaro for $5.1B
GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro | The Seattle ...
GSK buying cancer drugmaker Tesaro in $5.1 billion deal | New York Post
GlaxoSmithKline, Tesaro Agree to $5.1 Billion Deal - Business Insider
GlaxoSmithKline buys cancer drug company Tesaro for hefty USD 5.1 bn ...
Gsk tesaro | PPT
GSK slides after buying cancer firm Tesaro for hefty $5.1 billion, ET ...
GSK to boost cancer drugs pipeline with $5.1bn Tesaro purchase ...
La farmacéutica GSK compra Tesaro por 5.100 millones de dólares
TESARO Receives FDA Fast Track Designation for Niraparib and Initiates ...
Systeme | tesaro Gebäudeleittechnik GmbH
Tesaro - Crunchbase Company Profile & Funding
Together With Tesaro
TESARO Announces U.S. FDA Approval of VARUBI® IV for
Tesaro secures EU approval in specific ovarian cancer population ...
We're Obsessed With Your Success - Tesaro Logo - Free Transparent PNG ...
Bruselas aprueba un fármaco de Tesaro para combatir el cáncer de ovario ...
Tesaro
Karriere | tesaro Gebäudeleittechnik GmbH
Watch Tesaro Jumps on Report of Takeover Interest - Bloomberg
Referenzen | tesaro Gebäudeleittechnik GmbH
GSK bags Tesaro for $5B as it leaps back into commercial oncology and ...
TESARO Announces Immuno-Oncology Data Presentations at SITC 2018 Annual ...
Heizungsanlagen | tesaro Gebäudeleittechnik GmbH
Veristat Congratulates TESARO on the FDA Approval of ZEJULA™
TESARO International is officially open for business! SVP of ...
Legal Battle Heats Up Between GSK’s Tesaro and AnaptysBio Over PD-1 ...
GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion | The ...
GSK to acquire cancer drug maker Tesaro for $5.1 billion – 24/7 BIOPHARMA
Tesaro 2026 Company Profile: Valuation, Investors, Acquisition | PitchBook
Agreement to acquire TESARO | GSK
Logo Tesaro NASDAQ:TSRO Niraparib Brand PNG, Clipart, Blue, Brand ...
Logo Tesaro NASDAQ:TSRO Niraparib Brand, anti cancer transparent ...
Stock to watch: TESARO Inc (NASDAQ: TSRO)
UPDATE: GSK's Tesaro Sues AnaptysBio Over Current Jemperli Contract ...
TESARO, Inc. on LinkedIn: This month the TESARO team in France has ...
GSK acquires oncology firm Tesaro for $5.1 billion - Pharmafile
GSK to acquire cancer drug firm Tesaro | C&EN Global Enterprise
TESARO Summarizes TSR-042 Clinical Data Presented at AACR | TESARO, Inc ...
Glaxo to buy Tesaro for $75 per share
TESARO was acquired by GSK for $5.1 billion - LifeScienceHistory.com
In honor of Breast Cancer Awareness Month, TESARO associates donated ...
tesaro Gebäudeleittechnik GmbH | München, Würzburg, Regensburg und ...
Tesaro Beats Sales Views But Losses Up; Nektar Misses On Both Counts ...
GSK Unit Tesaro Sues AnaptysBio, Threatening Key Cancer Drug Jemperli ...
Tesaro Expects These Key Research Pipeline Milestones in 2019
Bayer to cut 12000 jobs, GSK buys cancer drugmaker Tesaro for US$ 5 ...
Core Portfolio - Ally Bridge Group
GlaxoSmithKline вернется в онкологический бизнес | МОСМЕДПРЕПАРАТЫ
GSK斥51亿美元现金收购Tesaro,以加强其制药业务-动脉网
Tesaro, un modello farmaceutico vincente nato negli Stati Uniti ed ora ...
GSK reaches agreement to acquire TESARO, an oncology focused ...
官宣!GSK将收购TESARO! - 药时代DrugTimes
Dostarlimab-gxly - Drug Targets, Indications, Patents - Synapse
TESARO, Inc. chemical industry news - chemXplore
.: GlaxoSmithKline Compra Tesaro, que está Especializada en Oncología ...
FDA approves new PARP ovarian cancer drug | The Pharmaletter
AnaptysBio, Inc.: Anaptys Initiates Litigation Against Tesaro, a GSK ...
PHARMA JONPI .: GlaxoSmithKline Compra Tesaro, que está Especializada ...
速递 | 重磅!葛兰素史克51亿美元收购TESARO,拓展肿瘤研发管线 - 知乎
알테오젠, GSK 자회사 Tesaro와 총 4200억 SC 기술수출 계약
创新=科学x技术x文化,GSK首席科学官如何为大型药企注入创新? - 每日头条
Illustration showing Intouch/GSK/Tesaro #OvaryAct campaign
GRAPHIC
TESARO’s new drug reduces risk of progression in ovarian cancer patients
Today we’ve announced our agreement to acquire TESARO, an oncology ...
GSK's Tesaro, AnaptysBio sue each other over Jemperli agreement
Pappas Portfolio - Pappas Capital
알테오젠, GSK Tesaro와 '도스탈리맙' SC 제형 개발 라이선스 계약
Kunden - brandlevel
Pharmaceutical Industry News Roundup, June 13th. | DEHUM
專注於癌症治療的生物製藥公司Tesaro獲得1.55億美元融資 - 每日頭條
聚焦|強強聯手 + I期臨床,TESARO加速腫瘤免疫療法 - 每日頭條
GSK completes acquisition of TESARO, an oncology focused ...
Tesaro’s Cancer Drug Meets Primary Endpoint in Late-Stage Trial - WSJ
CMAA报道 | TESARO新药获FDA批准,治疗化疗副作用!-赴美就医-远程会诊-大通福克斯美国本土机构
¿El cáncer está en su vida? | Cancer Support Community
Projektassistenz (m/w/d) München
TESARO卵巢癌新药III期临床获突破性进展-文章详情-华岭资本
Our Clients | Results by Design
TESARO, Inc. - FORM 8-K - EX-99.1 - March 16, 2016
TESARO-TESARO, Inc.-企业详情-InvestGO数据库-ByDrug-医药魔方数据库
TESARO, Inc. - FORM 8-K - EX-99.1 - January 7, 2013
Ovarian Cancer Awareness & Treatment | Boston, MA | Ovations for the Cure
Tesaro-Logo - AFSOS
TESARO, Inc. | LinkedIn
Tesaro, el laboratorio que rescata los medicamentos que otros abandonan
Athyrium Capital Management | Portfolio
Here’s What Tesaro’s Valuation Trend Indicates